Acute Renal Insufficiency Occurring during Intravenous Desferrioxamine Therapy
- 1 March 1979
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Haematology
- Vol. 22 (3) , 277-279
- https://doi.org/10.1111/j.1600-0609.1979.tb02809.x
Abstract
A patient of 14 years suffering from secondary haemosiderosis and thalassaemia major was treated with i.v. desferrioxamine in doses up to 3 g/d. Urine iron loss ranged from 46–158 mg/d. Despite improvement in cardiac and hepatic status the patient developed acute renal insufficiency of the pre renal type. The possible role of desferrioxamine in this complication is discussed. Desferrioxamine given s.c. or i.v. effects a marked urinary iron loss but its use may not be without significant complications.Keywords
This publication has 11 references indexed in Scilit:
- Excretion of iron in response to deferoxamine in sickle cell anemiaThe Journal of Pediatrics, 1978
- Chelation therapy in β-thalassemia major. I. Intravenous and subcutaneous deferoxamineThe Journal of Pediatrics, 1978
- Iron chelation therapy with deferoxamine in Cooley anemiaThe Journal of Pediatrics, 1978
- Intensive Iron-Chelation Therapy with Desferrioxamine in Iron-Loading AnaemiasClinical Science, 1978
- Treatment of iron overload in adults with continuous parenteral desferrioxamineThe American Journal of Medicine, 1977
- Safety of Intensive Chelation TherapyNew England Journal of Medicine, 1977
- SUBCUTANEOUS INFUSION AND INTRAMUSCULAR INJECTION OF DESFERRIOXAMINE IN PATIENTS WITH TRANSFUSIONAL IRON OVERLOADThe Lancet, 1976
- Reassessment of the Use of Desferrioxamine B in Iron OverloadNew England Journal of Medicine, 1976
- Desferrioxamine B: Reversible side effects of high daily dosesAnnals of Hematology, 1975
- Estimation of ferrioxamine and desferrioxamine in urineJournal of Clinical Pathology, 1964